Clinical Trial Update: ACT-TIL and ANV419 for Advanced Melanoma. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ACT-TIL and ANV419 in advanced melanoma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ACT-TIL
• ANV419

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Advanced Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING